Developments in factor Xa inhibitors for the treatment of thromboembolic disorders

YK Lee, MR Player - Medicinal Research Reviews, 2011 - Wiley Online Library
Thromboembolic diseases are the leading causes of morbidity and mortality in the
developed world. Anticoagulants provide effective treatment for venous or arterial …
被引用次数：47 相关文章

[引用][C] Developments in Factor Xa Inhibitors for the Treatment of Thromboembolic Disorders

YK Lee, MR Player - ChemInform, 2011 - Wiley Online Library
Abstract Review: 249 refs.

Developments in factor Xa inhibitors for the treatment of thromboembolic disorders

YK Lee, MR Player - Medicinal Research Reviews, 2011 - infona.pl
Thromboembolic diseases are the leading causes of morbidity and mortality in the
developed world. Anticoagulants provide effective treatment for venous or arterial …

Developments in factor Xa inhibitors for the treatment of thromboembolic disorders

YK Lee, MR Player - Medicinal research reviews, 2011 - pubmed.ncbi.nlm.nih.gov
Thromboembolic diseases are the leading causes of morbidity and mortality in the
developed world. Anticoagulants provide effective treatment for venous or arterial …

Developments in factor Xa inhibitors for the treatment of thromboembolic disorders.

YK Lee, MR Player - Medicinal Research Reviews, 2011 - europepmc.org
Thromboembolic diseases are the leading causes of morbidity and mortality in the
developed world. Anticoagulants provide effective treatment for venous or arterial …

Developments in Factor Xa Inhibitors for the Treatment of Thromboembolic Disorders

YK Lee, MR Player - Medicinal Research Reviews, 2011 - hero.epa.gov
Thromboembolic diseases are the leading causes of morbidity and mortality in the
developed world. Anticoagulants provide effective treatment for venous or arterial …